ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMGastos comerciales, generales y administrativos41.43 M53.15 M42.86 M40.39 M41.01 M62.75 M187 MInvestigación y desarrollo———————Beneficio operativo-508 K40.94 M42.66 M44.44 M76.29 M35.41 M198.79 MTotal de ingresos no operativos—-1.41 M-5.84 M————Gastos por intereses, netos de intereses capitalizados153.21 M149.36 M150.3 M158.12 M154.47 M156.14 M619.03 MIngresos no operativos, una vez deducidos los gastos por intereses—-149.36 M-150.3 M————Ingresos/gastos extraordinarios—-1.41 M-5.84 M————Beneficio antes de impuestos-508 K40.94 M42.66 M44.44 M76.29 M35.41 M198.79 MParticipación en los beneficios31.85 M-5.09 M-9.94 M-6.72 M-7.29 M-4.36 M-28.31 MImpuestos-45.54 M-10.56 M3.87 M-6.34 M-1.12 M-15.94 M-19.53 MParticipación minoritaria1.89 M1.49 M3.2 M2.66 M2.79 M3.13 M11.78 MOtros ingresos/gastos después de impuestos-25.08 M4.23 M-1.48 M-11.17 M-3.25 M1.56 M-14.33 MBeneficio neto antes de actividades interrumpidas58.73 M48.36 M71.46 M68.71 M72.99 M59.05 M272.21 MOperaciones suspendidas———————Beneficio neto58.73 M48.36 M71.46 M68.71 M72.99 M59.05 M272.21 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas56.84 M46.87 M68.26 M66.05 M70.2 M55.91 M260.43 MBeneficio básico por acción0.140.110.150.140.150.120.56Beneficio por acción diluido0.130.10.150.140.150.110.55Número medio de acciones ordinarias411.77 M439.93 M452.58 M456.03 M455.08 M476.19 M—Acciones diluidas416.37 M446.42 M459.09 M463.42 M462.62 M486.71 M—EBITDA316.06 M369.83 M397.07 M52.86 M86.13 M44.78 M580.84 MEBIT-508 K40.94 M42.66 M44.44 M76.29 M35.41 M198.79 MCosto de los ingresos1.12 B1.18 B1.25 B1.31 B1.42 B1.52 B5.5 BOtros costes de producción1.12 B1.18 B1.25 B1.31 B1.42 B1.52 B5.5 BAmortización y depreciación (flujo de caja)316.57 M328.89 M354.42 M8.43 M9.84 M9.37 M382.05 M
Ventas, Inc. Common Stock
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom.
As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion.
As of 2019, it is a Fortune 1000 corporation.